Opening book details…
About this Medicine article
Effect of concomitant dosing with acid-reducing agents and vemurafenib dose on survival in patients with BRAFV600 mutation–positive metastatic melanoma treated with vemurafenib ± cobimetinib by Lewis, Karl; Hauschild, Axel; Larkin, James; Ribas, Antoni; Flaherty, Keith T.; McArthur, Grant A.; Dréno, Brigitte; McKenna, Edward; Zhu, Qian; Mun, Yong; Ascierto, Paolo A. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Lewis, Karl; Hauschild, Axel; Larkin, James; Ribas, Antoni; Flaherty, Keith T.; McArthur, Grant A.; Dréno, Brigitte; McKenna, Edward; Zhu, Qian; Mun, Yong; Ascierto, Paolo A.
- Publisher
- Elsevier Science; Elsevier ; Elsevier Ltd.; Elsevier BV (ISSN 0959-8049)
- Published
- 2019
- Field
- Medicine (Health Sciences)